These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15236370)

  • 1. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate.
    Scheenen TW; Klomp DW; Röll SA; Fütterer JJ; Barentsz JO; Heerschap A
    Magn Reson Med; 2004 Jul; 52(1):80-8. PubMed ID: 15236370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.
    Scheenen TW; Gambarota G; Weiland E; Klomp DW; Fütterer JJ; Barentsz JO; Heerschap A
    Magn Reson Med; 2005 Jun; 53(6):1268-74. PubMed ID: 15906304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
    Scheenen TW; Heijmink SW; Roell SA; Hulsbergen-Van de Kaa CA; Knipscheer BC; Witjes JA; Barentsz JO; Heerschap A
    Radiology; 2007 Nov; 245(2):507-16. PubMed ID: 17848681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
    Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR
    Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study.
    Scheidler J; Hricak H; Vigneron DB; Yu KK; Sokolov DL; Huang LR; Zaloudek CJ; Nelson SJ; Carroll PR; Kurhanewicz J
    Radiology; 1999 Nov; 213(2):473-80. PubMed ID: 10551229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence--preliminary experience.
    van der Graaf M; van den Boogert HJ; Jager GJ; Barentsz JO; Heerschap A
    Radiology; 1999 Dec; 213(3):919-25. PubMed ID: 10580976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
    Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
    J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
    Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
    Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast 3D 1H spectroscopic imaging at 3 Tesla using spectroscopic missing-pulse SSFP with 3D spatial preselection.
    Schuster C; Dreher W; Geppert C; Leibfritz D
    Magn Reson Med; 2007 Jan; 57(1):82-9. PubMed ID: 17191249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional MR spectroscopic imaging of prostate cancer in vivo.
    Thomas MA; Nagarajan R; Huda A; Margolis D; Sarma MK; Sheng K; Reiter RE; Raman SS
    NMR Biomed; 2014 Jan; 27(1):53-66. PubMed ID: 23904127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging.
    Kaji Y; Kurhanewicz J; Hricak H; Sokolov DL; Huang LR; Nelson SJ; Vigneron DB
    Radiology; 1998 Mar; 206(3):785-90. PubMed ID: 9494502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
    Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
    Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.
    Lagemaat MW; Vos EK; Maas MC; Bitz AK; Orzada S; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
    Invest Radiol; 2014 May; 49(5):363-72. PubMed ID: 24335715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.
    Kim DH; Margolis D; Xing L; Daniel B; Spielman D
    Magn Reson Med; 2005 May; 53(5):1177-82. PubMed ID: 15844143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.